J. W. Faigle

1.6k total citations
48 papers, 1.3k citations indexed

About

J. W. Faigle is a scholar working on Pharmacology, Molecular Biology and Spectroscopy. According to data from OpenAlex, J. W. Faigle has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Molecular Biology and 11 papers in Spectroscopy. Recurrent topics in J. W. Faigle's work include Pharmacogenetics and Drug Metabolism (13 papers), Analytical Chemistry and Chromatography (10 papers) and Analytical Methods in Pharmaceuticals (7 papers). J. W. Faigle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Analytical Chemistry and Chromatography (10 papers) and Analytical Methods in Pharmaceuticals (7 papers). J. W. Faigle collaborates with scholars based in Switzerland, Germany and United States. J. W. Faigle's co-authors include H. Stierlin, W. Dieterle, H.‐P. KRIEMLER, H. Keberle, T. WINKLER, Karl Schmid, W Theobald, A. Sallmann, W. Rieß and Helmut Schütz and has published in prestigious journals such as Nature, The Lancet and Annals of the New York Academy of Sciences.

In The Last Decade

J. W. Faigle

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. W. Faigle Switzerland 19 403 372 251 221 202 48 1.3k
Harvey M. Solomon United States 24 264 0.7× 272 0.7× 234 0.9× 513 2.3× 150 0.7× 76 1.7k
L Balant Switzerland 26 422 1.0× 370 1.0× 257 1.0× 395 1.8× 159 0.8× 85 1.9k
M. Gibaldi United States 20 421 1.0× 441 1.2× 345 1.4× 217 1.0× 136 0.7× 50 1.4k
James T. Doluisio United States 21 156 0.4× 345 0.9× 339 1.4× 261 1.2× 192 1.0× 53 1.4k
JoAnn Scatina United States 22 681 1.7× 251 0.7× 318 1.3× 483 2.2× 84 0.4× 56 1.6k
J. Godbillon Switzerland 24 188 0.5× 286 0.8× 168 0.7× 107 0.5× 376 1.9× 61 1.3k
H. J. Dengler Germany 19 404 1.0× 179 0.5× 230 0.9× 238 1.1× 135 0.7× 44 1.2k
Hildegard Spahn‐Langguth Germany 21 403 1.0× 237 0.6× 694 2.8× 346 1.6× 160 0.8× 37 1.7k
Benedetta C. Sallustio Australia 24 583 1.4× 303 0.8× 390 1.6× 328 1.5× 143 0.7× 85 1.6k
Jean‐Paul Thénot United States 18 209 0.5× 116 0.3× 110 0.4× 159 0.7× 126 0.6× 38 1.1k

Countries citing papers authored by J. W. Faigle

Since Specialization
Citations

This map shows the geographic impact of J. W. Faigle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. Faigle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. Faigle more than expected).

Fields of papers citing papers by J. W. Faigle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. W. Faigle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. Faigle. The network helps show where J. W. Faigle may publish in the future.

Co-authorship network of co-authors of J. W. Faigle

This figure shows the co-authorship network connecting the top 25 collaborators of J. W. Faigle. A scholar is included among the top collaborators of J. W. Faigle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. Faigle. J. W. Faigle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lønning, Per Eystein, Jürgen Geisler, Dag Clement Johannessen, et al.. (2001). Pharmacokinetics and metabolism of formestane in breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology. 77(1). 39–47. 21 indexed citations
2.
Blum, W., J. W. Faigle, Ulrike Pfaar, & A. Sallmann. (1996). Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 685(2). 251–263. 29 indexed citations
3.
Waldmeier, Felix, G. Kaiser, Roland Ackermann, et al.. (1991). The disposition of [14C]-labelled benazepril HC1 in normal adult volunteers after single and repeated oral dose. Xenobiotica. 21(2). 251–261. 26 indexed citations
4.
Faigle, J. W. & G. P. Menge. (1990). Metabolic Characteristics of Oxcarbazepine (®Trileptal) and their Beneficial Implications for Enzyme Induction and Drug Interactions. Behavioural Neurology. 3(1). 21–30. 33 indexed citations
5.
Faigle, J. W., I. Böttcher, J. Godbillon, et al.. (1988). A New Metabolite of Diclofenac Sodium in Human Plasma. Xenobiotica. 18(10). 1191–1197. 33 indexed citations
6.
Faigle, J. W., et al.. (1987). Structures and Mutagenic Properties of Products Obtained by C‐Nitrosation of Opipramol. Helvetica Chimica Acta. 70(5). 1296–1301. 3 indexed citations
7.
Schütz, Helmut, et al.. (1986). The metabolism of14C-oxcarbazepine in man. Xenobiotica. 16(8). 769–778. 128 indexed citations
8.
Dieterle, W. & J. W. Faigle. (1981). Species differences in the disposition and metabolism of sulfinpyrazone. Xenobiotica. 11(8). 559–568. 8 indexed citations
9.
10.
Rieß, W., H. Stierlin, P.H. Degen, et al.. (1978). Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren. Scandinavian Journal of Rheumatology. 7(sup22). 17–29. 166 indexed citations
11.
Dieterle, W., et al.. (1977). Biotransformation and pharmacokinetics of acenocoumarol (Sintrom�) in man. European Journal of Clinical Pharmacology. 11(5). 367–375. 42 indexed citations
12.
Dieterle, W., J. Wagner, & J. W. Faigle. (1976). Binding of chlorthalidone (Hygroton�) to blood components in man. European Journal of Clinical Pharmacology. 10(1). 37–42. 28 indexed citations
13.
Dieterle, W., et al.. (1975). Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan�) in man. European Journal of Clinical Pharmacology. 9(2-3). 135–145. 55 indexed citations
14.
Faigle, J. W.. (1971). Blood Levels of a Schistosomicide in Relation to Liver Function and Side Effects. Acta Pharmacologica et Toxicologica. 29(s3). 233–239. 7 indexed citations
15.
16.
Faigle, J. W. & H. Keberle. (1969). METABOLISM OF NIRIDAZOLE IN VARIOUS SPECIES, INCLUDING MAN. Annals of the New York Academy of Sciences. 160(2). 544–557. 37 indexed citations
17.
Hess, R., et al.. (1966). Selective Uptake of an Antibilharzial Nitrothiazole Compound by Schistosoma mansoni. Nature. 210(5039). 964–965. 27 indexed citations
18.
Keberle, H., P. Loustalot, R Maller, J. W. Faigle, & Karl Schmid. (1965). BIOCHEMICAL EFFECTS OF DRUGS ON THE MAMMALIAN CONCEPTUS. Annals of the New York Academy of Sciences. 123(1). 252–262. 18 indexed citations
19.
Faigle, J. W., H. Müller, Wolfgang von Philipsborn, & P. Karrer. (1964). Zur Konfiguration des natürlichen Capsanthins und Capsorubins. Helvetica Chimica Acta. 47(3). 741–745. 5 indexed citations
20.
Faigle, J. W., et al.. (1962). Thalidomide and Glutethimide. BMJ. 2(5305). 672–673. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvey M. Solomon Breakdown of academic impact, for papers by L Balant Breakdown of academic impact, for papers by M. Gibaldi Breakdown of academic impact, for papers by James T. Doluisio Breakdown of academic impact, for papers by JoAnn Scatina Breakdown of academic impact, for papers by J. Godbillon Breakdown of academic impact, for papers by H. J. Dengler Breakdown of academic impact, for papers by Hildegard Spahn‐Langguth Breakdown of academic impact, for papers by Benedetta C. Sallustio Breakdown of academic impact, for papers by Jean‐Paul Thénot
Rankless by CCL
2026